SinFonia aims to produce novel fluorochemicals in a biological way. Materials containing the element fluorine (F) are extremely important in our modern world, with applications in electronics, healthcare, automotive and wearables. Currently these fluorochemicals are exclusively synthesized using chemical methods. SinFonia wants to change that by using synthetic biology. The project aims to engineer the metabolically-versatile bacterium Pseudomonas putida to execute biofluorinations for generating novel fluoropolymers from renewable substrates.

  • SinFonia is a Horizon 2020 EU project launched in 2019 and scheduled to run for the next 3 years with funding of around 7,9 million Euros.
  • The project is led and coordinated by scientists at the Novo Nordisk Foundation Center for Biosustainability, which was established in 2011 in collaboration with the Technical University of Denmark.
  • SinFonia is designed as a truly interdisciplinary project. The consortium is composed of 8 research institutions, 1 large industry partner and 4 SMEs.

SinFonia has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 814418.

  • The Novo Nordisk Foundation Center for Biosustainability – Technical University of Denmark (Denmark)
  •  Max Planck Institute of Molecular Plant Biology (Germany)
  • Masaryk University (Czech Republic)
  • University of St. Andrews (UK)
  • Consejo Superior de Investigaciones Científicas (Spain)
  • University of Tartu (Estonia)
  • University of Luxembourg (Luxembourg)
  • BioPlastech Ltd. (Ireland)
  • Biofaction KG (Austria)
  • Altar (France)
  • IN S.r.l. – Financing and Project Management (Italy)
  • IFEU – Institut für Energie- und Umweltforschung Heidelberg GmbH (Germany)

Biofaction will facilitate the science society interface for SinFonia. We will contribute to the project by working on public engagement, both on- and offline, as well as analysing analyzing the public perception of the project – specifically the use of synthetic biology and of engineered bacteria as future source of value-added F-chemicals.